Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Current Leases (2016 - 2025)

Historic Current Leases for Niagen Bioscience (NAGE) over the last 15 years, with Q3 2025 value amounting to $976000.0.

  • Niagen Bioscience's Current Leases fell 317.46% to $976000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $976000.0, marking a year-over-year decrease of 317.46%. This contributed to the annual value of $982000.0 for FY2024, which is 4211.29% up from last year.
  • Niagen Bioscience's Current Leases amounted to $976000.0 in Q3 2025, which was down 317.46% from $957000.0 recorded in Q2 2025.
  • In the past 5 years, Niagen Bioscience's Current Leases registered a high of $1.0 million during Q3 2024, and its lowest value of $447000.0 during Q3 2021.
  • For the 5-year period, Niagen Bioscience's Current Leases averaged around $765777.8, with its median value being $736000.0 (2023).
  • In the last 5 years, Niagen Bioscience's Current Leases tumbled by 2610.76% in 2021 and then soared by 5302.01% in 2022.
  • Niagen Bioscience's Current Leases (Quarter) stood at $528000.0 in 2021, then rose by 28.79% to $680000.0 in 2022, then increased by 1.62% to $691000.0 in 2023, then skyrocketed by 42.11% to $982000.0 in 2024, then decreased by 0.61% to $976000.0 in 2025.
  • Its Current Leases was $976000.0 in Q3 2025, compared to $957000.0 in Q2 2025 and $939000.0 in Q1 2025.